CIM Chimera reports Q4 2025 earnings per share above analyst projections stock registers mild daily gains Gilead Sciences GILD Arcellx Acquisition Clearance and Bullish Analyst Upgrade Underpin NearTerm Upside Catalysts Pilgrims PPC Stock Overvalued vs Peers 024 20260427